Jim Fang

1.7k total citations · 1 hit paper
29 papers, 1.4k citations indexed

About

Jim Fang is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jim Fang has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jim Fang's work include Pharmacogenetics and Drug Metabolism (7 papers), Phytochemicals and Antioxidant Activities (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Jim Fang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Phytochemicals and Antioxidant Activities (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Jim Fang collaborates with scholars based in Canada, United Kingdom and United States. Jim Fang's co-authors include P. H. Yu, Michel Bourin, Glen B. Baker, J. W. Gorrod, Gordon McKay, Dongmei Zuo, A. A. Boulton, David M. Briscoe, Bárbara Davis and Hugh A. Semple and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and FEBS Letters.

In The Last Decade

Jim Fang

28 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioavailability of anthocyanins

2014 340 citations Jim Fang Drug Metabolism Reviews profile →

Peers

Countries citing papers authored by Jim Fang

Since Specialization

Citations

This map shows the geographic impact of Jim Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Fang more than expected).

Fields of papers citing papers by Jim Fang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Fang. The network helps show where Jim Fang may publish in the future.

Co-authorship network of co-authors of Jim Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Fang. A scholar is included among the top collaborators of Jim Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Fang. Jim Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 1 study to evaluate the safety, pharmacokinetics, and efficacy of the first-in-class cyclin A/B RxL inhibitor CID-078, an orally bioavailable, cell-permeable macrocycle. 2025 ·Journal of Clinical Oncology ·Nehal J. Lakhani, (unknown), (unknown), (unknown), Timothy A. Yap, Afshin Dowlati, Vivek Subbiah, Judy S. Wang, Manali Bhave, Kyaw Zin Thein, Jim Fang, Edward M. Connor, Lifen Liu, (unknown), Lukas Makris, (unknown), Lisa M. Kopp, Michael C. Cox, Shivaani Kummar	0
2	Classification of fruits based on anthocyanin types and relevance to their health effects 2015 ·Nutrition ·Jim Fang	166
3	Bioavailability of anthocyanins breakdown → 2014 ·Drug Metabolism Reviews ·Jim Fang	340
4	In vitro Characterization of the Oxidation of a Pyridinium Metabolite of Haloperidol by Human Placenta: The Effect of Smoking 2012 ·Journal of Pharmacy & Pharmaceutical Sciences ·Jim Fang, (unknown)	1
5	Determination of metoprolol, and its four metabolites in dog plasma 2004 ·Journal of Chromatography B ·Jim Fang, Hugh A. Semple, (unknown)	40
6	Enantioselective Analysis of Ritalinic Acids in Biological Samples by Using a Protein-Based Chiral Stationary Phase 2003 ·Pharmaceutical Research ·Jianhua Zhang, Yulin Deng, Jim Fang, Gordon McKay	14
7	Determination of clozapine, and its metabolites, N-desmethylclozapine and clozapine N-oxide in dog plasma using high-performance liquid chromatography 2002 ·Journal of Chromatography B ·(unknown), (unknown), Gordon McKay, John W. Hubbard, Jim Fang	26
8	Binding of a de novo designed peptide to specific glycosaminoglycans 2000 ·FEBS Letters ·G. Jayaraman, (unknown), (unknown), Kun‐Yi Chien, Jim Fang, Ping‐Chiang Lyu	19
9	Dose staggering as a strategy to reduce drug–drug interactions due to reversible enzyme inhibition between orally administered drugs with high first pass effect: a computer simulation study 2000 ·Biopharmaceutics & Drug Disposition ·Jim Fang, (unknown), John W. Hubbard, E. M. Hawes, K.K. Midha	6
10	The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection 2000 ·Pediatric Transplantation ·Mark Denton, Stacy F. Davis, Michelle A. Baum, Michael Melter, Marlies E. J. Reinders, Andrea Exeni, Dmitry Samsonov, Jim Fang, Peter Ganz, David M. Briscoe	73
11	Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4 1999 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Jim Fang, Michel Bourin, Glen B. Baker	202
12	Metabolism, Pharmacogenetics, and Metabolic Drug–Drug Interactions of Antipsychotic Drugs 1999 ·Cellular and Molecular Neurobiology ·Jim Fang, J. W. Gorrod	36
13	Current understanding of chemokine involvement in allograft transplantation 1999 ·Pediatric Transplantation ·Michael Melter, Gearoid M. McMahon, Jim Fang, Peter Ganz, David M. Briscoe	29
14	Chapter 12 Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties 1995 ·Progress in brain research ·P. H. Yu, Bárbara Davis, (unknown), Dongmei Zuo, Jim Fang, Chien‐Tsai Lai, (unknown), I.A. Paterson, A. A. Boulton	18
15	Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxinN-methyl-4-phenylpyridinium (MMP+) towards cultured dopaminergic neuroblastoma cells 1995 ·Psychopharmacology ·Jim Fang, Dongmei Zuo, P. H. Yu	38
16	Lack of protective effect of R(-)-deprenyl on programmed cell death of mouse thymocytes induced by dexamethasone 1995 ·Life Sciences ·Jim Fang, Dongmei Zuo, P. H. Yu	16
17	Effect of haloperidol and its metabolites on dopamine and noradrenaline uptake in rat brain slices 1995 ·Psychopharmacology ·Jim Fang, P. H. Yu	26
18	Effect of l-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake 1994 ·Neuropharmacology ·Jim Fang, P. H. Yu	44
19	Neuroprotective Effects of Some Monoamine Oxidase‐B Inhibitors Against DSP‐4‐Induced Noradrenaline Depletion in the Mouse Hippocampus 1994 ·Journal of Neurochemistry ·P. H. Yu, Bárbara Davis, Jim Fang, A. A. Boulton	44
20	On the metabolism of haloperidol 1993 ·Xenobiotica ·J. W. Gorrod, Jim Fang	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact